Top Buy
Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Vertex Pharmaceuticals Inc. | 59 | 2 | 0 | 0 | €445.60 | €450.36 | 1.069% |
Evotec SE | 9 | 2 | 3 | 0 | €6.63 | €10.00 | 50.830% |
MorphoSys AG | 7 | 0 | 0 | 0 | €67.40 | €65.00 | -3.561% |
Merck KGaA | 5 | 1 | 0 | 0 | €174.60 | €172.00 | -1.489% |
QIAGEN NV | 12 | 0 | 0 | 0 | €40.47 | €47.52 | 17.415% |
AstraZeneca plc | 2 | 0 | 0 | 0 | €157.70 | €165.00 | 4.629% |
Sanofi S.A. | 4 | 0 | 0 | 0 | €101.66 | €109.00 | 7.220% |
Novo Nordisk A/S | 6 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
Pfizer Inc. | 31 | 4 | 0 | 0 | €25.93 | €41.47 | 59.969% |
Johnson & Johnson | 40 | 1 | 0 | 0 | €148.32 | €187.62 | 26.494% |
Merck & Co. Inc. | 33 | 1 | 1 | 0 | €106.20 | €125.91 | 18.557% |
Amgen Inc. | 28 | 0 | 0 | 0 | €298.90 | €304.82 | 1.980% |
Regeneron Pharmaceuticals Inc. | 47 | 1 | 2 | 0 | €1,064.5 | €1,091.9 | 2.573% |
Gilead Sciences Inc | 12 | 1 | 0 | 0 | €71.74 | €84.81 | 18.221% |
Abbott Laboratories | 21 | 0 | 1 | 0 | €101.84 | €116.48 | 14.376% |
Eli Lilly Corp. | 69 | 0 | 2 | 0 | €849.30 | €860.00 | 1.260% |
Viatris Inc. | 1 | 0 | 0 | 0 | €10.74 | - | - |
Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.31 | €35.01 | 33.049% |